All Oncology News

The OncLive® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses.

NDAs Filed for Two Melanoma Drugs

August 7th 2012

GlaxoSmithKline is seeking the FDA's approval for single-agent use of dabrafenib and trametinib, two targeted therapies for the treatment of patients with metastatic melanoma who harbor BRAF V600 gene mutations.

Combination of Anastrozole and Fulvestrant Improves Survival in Metastatic Breast Cancer

August 7th 2012

Researchers found that when anastrozole and fulvestrant are given in combination that patients with metastatic breast cancer experienced longer periods of PFS and OS.

Hepatitis C Infection

August 6th 2012

Transmission via healthcare workers is still occurring.

FDA Approves Aflibercept for Metastastic Colorectal Cancer

August 3rd 2012

The FDA announced that aflibercept has been approved to treat metastatic colorectal cancer when given in combination with the FOLFIRI chemotherapy regimen.

Patient Engagement

July 31st 2012

Principles for patient-centered care recently were released by the NAQC.

Geriatric Emergency Departments

July 25th 2012

Coming soon to a hospital near you?

FDA Approves Carfilzomib for Relapsed Multiple Myeloma

July 23rd 2012

The FDA approved carfilzomib for patients with multiple myeloma who have received at least two prior lines of therapy.

FDA Approves Everolimus for Advanced Breast Cancer

July 23rd 2012

The FDA has approved everolimus for treating patients with hormone receptor-positive, HER2 negative breast cancer, when given in combination with the aromatase inhibitor exemestane.

The Nurse Practitioner Workforce

July 17th 2012

We know more NPs are needed, but how many will be needed to meet future healthcare needs?

FDA Approves Cetuximab Plus FOLFIRI for Metastatic Colorectal Cancer

July 10th 2012

The FDA has approved cetuximab in combination with the FOLFIRI regimen as a first-line treatment for patients with mCRC who express EGFR and wild-type KRAS mutations.

The Reality of End-of-Life Care

July 9th 2012

Much remains to be done in the USA to improve the care of patients at end-of-life.

Cetuximab Fails to Extend PFS in Advanced Gastric Cancer

July 5th 2012

The phase III EXPAND trial of cetuximab in combination with standard chemotherapy for patients with advanced gastric adenocarcinoma failed to show a significant improvement in progression-free survival.

Case-Based Discussion: Sequencing Prostate Cancer Therapy

July 3rd 2012

Case-based discussion on sequencing prostate cancer therapies for a 72-year-old man with a metastatic adenocarcinoma with small-cell components, a PSA score of 80, and a Gleason score of 10.

Oncology Leaders Praise Health Law Ruling-With Caveats

June 28th 2012

Leaders in the oncology care and research communities largely applauded the US Supreme Court ruling Thursday that upholds the Affordable Care Act.

Nursing Shortage or Shortage of Nursing Care?

June 25th 2012

Recent survey suggests it's a shortage of care, not nurses.

ODAC Supports Carfilzomib for Relapsed Multiple Myeloma

June 20th 2012

ODAC voted 11-0 in support of carfilzomib as a new treatment option for patients with multiple myeloma, despite side effect concerns raised by the FDA.

Health Insurance Gaps

June 20th 2012

2011 survey finds 25% of adults experienced a gap in health insurance last year.

Sensational Medical Reporting

June 13th 2012

Is the list of "10 shocking medical mistakes" informational or just sensational?

Pertuzumab Gains Approval as Dual Anti-HER2 Breast Cancer Treatment

June 11th 2012

The FDA has approved pertuzumab combined with trastuzumab and docetaxel for patients who have not received prior treatment for HER2-positive metastatic breast cancer.

NSAIDs for Skin Cancer Prevention

May 31st 2012

Researchers find that people who took NSAIDs were less likely to develop skin cancer.